<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5E9E5F30-A127-4243-AB12-B19B7A50D0E7"><gtr:id>5E9E5F30-A127-4243-AB12-B19B7A50D0E7</gtr:id><gtr:name>Unlisted</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Central Admin - Research Services</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E9E5F30-A127-4243-AB12-B19B7A50D0E7"><gtr:id>5E9E5F30-A127-4243-AB12-B19B7A50D0E7</gtr:id><gtr:name>Unlisted</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/285E8C75-E110-481B-A875-14EE0768098D"><gtr:id>285E8C75-E110-481B-A875-14EE0768098D</gtr:id><gtr:firstName>Robert</gtr:firstName><gtr:otherNames>Duncan</gtr:otherNames><gtr:surname>Campbell</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0600681"><gtr:id>924900AC-CC4A-4EF7-BFD9-A7F50541CCA2</gtr:id><gtr:title>Functional Characterisation of Novel Disease Susceptibility Genes in the Human Major Histocompatibility Complex</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0600681</gtr:grantReference><gtr:abstractText>Our immune system is critical to our ability to fight bacterial and viral infections. It is controlled by a large number of proteins which are found on the surface of cells that circulate in the blood called T lymphocytes, B lymphocytes and macrophages. Some of these cell surface proteins are directly involved in the recognition and elimination of bacteria and viruses from the body. However, this cannot happen without the help of other cell surface proteins which allow lymphocytes and macrophages to interact with one another and this stimulates or dampens down the immune response. Unfortunately, sometimes the immune response gets out of control and begins to attack one?s own tissue. The results of this are conditions called autoimmune diseases, a common example of which is Rheumatoid Arthritis.

The purpose of this research is to characterise two of these cell surface proteins which lie in a region of the human genome associated with susceptibility to Rheumatoid Arthritis, to understand their roles in the normal immune response through identifying which cells they are found on and which other cell surface proteins they interact with. By combining this functional characterisation with research to identify the differences which exist in these cell surface proteins in different people we hope to understand how these proteins can cause some people to be more susceptible to developing Rheumatoid Arthritis.</gtr:abstractText><gtr:technicalSummary>The Major Histocompatibility Complex (MHC) is a key region of the human genome as it contains genes that are critical for our immune system to mount a response to a variety of different pathogens. We have identified 2 genes (G6B and G6F), lying adjacent to one another in a segment of the MHC class III region strongly associated with susceptibility to Rheumatoid Arthritis, that are of major interest as they encode novel cell surface co-signalling molecules. Our initial functional characterisation of G6B indicates that it could be a new member of the family of co-inhibitory receptors while G6F could be a novel co-stimulatory receptor involved in cellular activation.

We propose to carry out a thorough transcriptional and functional analysis of G6B and G6F to establish where the proteins are expressed, what controls their expression, and what cellular ligands they bind to. Identification of their ligands will be achieved using the novel reverse transfection cell microarrays we have developed, which will allow us to analyse large numbers of cell surface proteins uniquely in the context of their correct expression at the cell surface. Novel receptor-ligand interactions will be characterised further and this will be followed up biochemically in more detail using BIAcore analysis. The functional consequences of polymorphisms that affect coding sequences, as well as those that might affect expression of the genes, will be elucidated. In relation to fully understanding the roles of the cell surface molecules in cellular activation, and consequently in disease susceptibility, we will investigate using whole genome microarrays the gene expression programmes which are evoked upon stimulation of these receptors. This combined knowledge will provide a picture of the molecular programmes by which the receptors and their ligands augment or inhibit immune responses and the key genes involved. The data will also provide a strong foundation for further investigations of the receptors and the cell types they are expressed on in the context of their involvement in susceptibility to Rheumatoid Arthritis.</gtr:technicalSummary><gtr:fund><gtr:end>2011-02-28</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>818461</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Sir William Dunn School of Pathology</gtr:department><gtr:description>Marion Brown</gtr:description><gtr:id>FEA039E4-7F0A-4BAC-9576-BDB2E362779A</gtr:id><gtr:impact>We have quantified the strength of the interactions between the three major inhibitory platelet receptors G6B-B, PECAM-1 and CEACAM-1L and the SH2 domain containing phosphatases SHP-1 and SHP-2 in order to establish a biochemical hierarchy that will aid in our understanding of how these receptors coordinate their signalling pathways to set a threshold of platelet activation and to regulate the extent of thrombosis. Some of this work has been published in PLOS One.</gtr:impact><gtr:outcomeId>937E72484DA-1</gtr:outcomeId><gtr:partnerContribution>Access to BIAcore facilities and interpretation of data</gtr:partnerContribution><gtr:piContribution>We prepared all the purified proteins and reagents necessary for the BIAcore studies</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Sir William Dunn School of Pathology</gtr:department><gtr:description>Neil Barclay</gtr:description><gtr:id>6BF6D658-BA09-4C30-901C-229F96FC4CAC</gtr:id><gtr:impact>The availability of clones and expressed proteins and domains for signalling molecules from the OMC has been instrumental in the success of our work. It has allowed us to prepared purified proteins/domains for our BIAcore studies. These studies have quantified the strength of the interactions between the three major inhibitory platelet receptors G6B-b, PECAM-1 and CEACAM-1L and the SH2 domain containing phosphatases SHP-1 and SHP-2 in order to establish a biochemical hierarchy that will aid in our understanding of how these receptors coordinate their signalling pathways to set a threshold of platelet activation and to regulate the extent of thrombosis. Some of this work has been published in PLOS One</gtr:impact><gtr:outcomeId>0F5A4A65DDD-1</gtr:outcomeId><gtr:partnerContribution>Access to the Oxford Module Consortium</gtr:partnerContribution><gtr:piContribution>Testing of clones and expressed proteins and their domains</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Pharmacology</gtr:department><gtr:description>Grant Churchill</gtr:description><gtr:id>2D0BE272-6904-493E-B3A8-FDE5420BBC63</gtr:id><gtr:impact>This collaboration has allowed us to investigate the role of NAADP in human platelet activation. The results from this study have been published in the Biochemical Journal.</gtr:impact><gtr:outcomeId>039E9CD557D-1</gtr:outcomeId><gtr:partnerContribution>Provision of NAADP and the novel NAADP receptor antagonist, Ned19</gtr:partnerContribution><gtr:piContribution>We investigated the importance of NAADP in agonist-induced platelet activation. Using radioligand binding assays, we identified an NAADP binding site in platelets, strongly suggestive of a NAADP receptor for which the novel NAADP receptor antagonist, Ned-19, can compete. Ned-19 inhibited CRP and thrombin-induced Ca2+ release as well as platelet aggregation and granule secretion.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Reading</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Biological Sciences Reading</gtr:department><gtr:description>Jon Gibbins</gtr:description><gtr:id>75CAB99C-F2FA-4FF3-B5B5-708C614878BF</gtr:id><gtr:impact>A peer reviewed publication in the Biochemical Journal has resulted from this collaboration.</gtr:impact><gtr:outcomeId>A5F0FF139BB-1</gtr:outcomeId><gtr:partnerContribution>The collaboration has allowed access to methods, expertise and equipment for important platelet functional assays.</gtr:partnerContribution><gtr:piContribution>We have used the collaboration to carry out a number of key platelet functional assays in order to characterise the function of the platelet inhibitory receptor G6B in greater detail.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>College of Life and Environmental Sciences</gtr:department><gtr:description>Steve Watson and Yotis Senis</gtr:description><gtr:id>D07F8777-BD11-432B-9CFA-2209A38BAA95</gtr:id><gtr:impact>This collaboration has led to the generation of G6B constitutive and conditional knockout mice in Birmingham. The work describing the characterisation of the G6B constitutive knockout mouse has been published in Science Signalling.</gtr:impact><gtr:outcomeId>025490E1BBC-1</gtr:outcomeId><gtr:partnerContribution>Access to expertise concerning platelet functional assays. Development of G6B constitutive and conditional knockout mice.</gtr:partnerContribution><gtr:piContribution>Information on the mouse G6B gene and expertise in molecular biology.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Talk to AS/A Level Students doing Biology at Matthew Arnold School, Oxford</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>3D9F9B00-C5A9-4003-899E-E8D9253DC37C</gtr:id><gtr:impact>Talks and practicals by a post-doctoral researcher funded by the grant to AS/A Level Students doing Biology at Matthew Arnold School, Oxford.

The talks were well received and the post-doctoral researcher will visit the school next year to give more talks.</gtr:impact><gtr:outcomeId>19AF5EB7D1F</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2008,2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>113900</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF Project Grant</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>66677EE2-633A-4263-8353-09C228729E51</gtr:id><gtr:outcomeId>kBNJrUHkn660</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>151000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF Project Grant</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>6E2BD2B2-DC3D-4B24-B360-7285FE151DD4</gtr:id><gtr:outcomeId>A95A1B3B6F20</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-08-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>89216BF8-7EA8-41C8-94AE-A70B581F2154</gtr:id><gtr:title>Molecular Aspects of Innate and Adaptive Immunity -</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da264ba16d78320a30eb41f9dd95a7ed"><gtr:id>da264ba16d78320a30eb41f9dd95a7ed</gtr:id><gtr:otherNames>Campbell R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:isbn>978-0-85404-698-0</gtr:isbn><gtr:outcomeId>306710FB57F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>37DF9BEC-26BF-4640-8E35-F2489036258E</gtr:id><gtr:title>Characterization of the five novel Ly-6 superfamily members encoded in the MHC, and detection of cells expressing their potential ligands.</gtr:title><gtr:parentPublicationTitle>Protein science : a publication of the Protein Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6aefb42c6bd5c5b9165dac1885914e07"><gtr:id>6aefb42c6bd5c5b9165dac1885914e07</gtr:id><gtr:otherNames>Mallya M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0961-8368</gtr:issn><gtr:outcomeId>430C3852C83</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D17DD940-2E21-452D-BBCA-33C49B359F7D</gtr:id><gtr:title>The novel inhibitory receptor G6B is expressed on the surface of platelets and attenuates platelet function in vitro.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff9dab4a6ebb50cf7ea6861389d7404e"><gtr:id>ff9dab4a6ebb50cf7ea6861389d7404e</gtr:id><gtr:otherNames>Newland SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>9290EBA0A12</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>924B4745-382B-4613-9ECF-46DE899EF20A</gtr:id><gtr:title>Molecular Aspects of Innate and Adaptive Immunity -</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da264ba16d78320a30eb41f9dd95a7ed"><gtr:id>da264ba16d78320a30eb41f9dd95a7ed</gtr:id><gtr:otherNames>Campbell R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:isbn>978-0-85404-698-0</gtr:isbn><gtr:outcomeId>42B4FF5C004</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59E214B9-ACBC-4681-B4AE-1C18F4360178</gtr:id><gtr:title>An investigation of hierachical protein recruitment to the inhibitory platelet receptor, G6B-b.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/12e7324c929116c8b00a5e119d7451b7"><gtr:id>12e7324c929116c8b00a5e119d7451b7</gtr:id><gtr:otherNames>Coxon CH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>Xt3jwKfXVGg</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>769A9508-44FA-4336-AEF1-593C66491EEB</gtr:id><gtr:title>Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c51fc27418fa0f0619dabac8576d703"><gtr:id>2c51fc27418fa0f0619dabac8576d703</gtr:id><gtr:otherNames>Nejentsev S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>245FDCE4315</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6492226A-07B2-4F61-B258-AE5ABFFF63C8</gtr:id><gtr:title>NAADP regulates human platelet function.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/12e7324c929116c8b00a5e119d7451b7"><gtr:id>12e7324c929116c8b00a5e119d7451b7</gtr:id><gtr:otherNames>Coxon CH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>B3NKegJJfsj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E39DA2F-08BF-40B9-9F00-DCB6413D512F</gtr:id><gtr:title>Regulation of expression of two LY-6 family genes by intron retention and transcription induced chimerism.</gtr:title><gtr:parentPublicationTitle>BMC molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/653c648f8ba3a9b096ce08aea0614090"><gtr:id>653c648f8ba3a9b096ce08aea0614090</gtr:id><gtr:otherNames>Calvanese V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1471-2199</gtr:issn><gtr:outcomeId>BDDA78F845E</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0600681</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>